An international research collaborative has determined that a promising anti-malarial compound tricks the immune system to rapidly destroy red blood cells infected with the malaria parasite but leave healthy cells unharmed.
St. Jude Children’s Research Hospital scientists led the study, which appears in the current online early edition of the Proceedings of the National Academy of Sciences (PNAS).
The compound, (+)-SJ733, was developed from a molecule identified in a previous St. Jude-led study that helped to jumpstart worldwide anti-malarial drug development efforts. Malaria is caused by a parasite spread through the bite of an infected mosquito. The disease remains a major health threat to more than half the world’s population, particularly children. The World Health Organization estimates that in Africa a child dies of malaria every minute.
In this study, researchers determined that (+)-SJ733 uses a novel mechanism to kill the parasite by recruiting the immune system to eliminate malaria-infected red blood cells. In a mouse model of malaria, a single dose of (+)-SJ733 killed 80 percent of malaria parasites within 24 hours. After 48 hours the parasite was undetectable.
Planning has begun for safety trials of the compound in healthy adults.
Laboratory evidence suggests that the compound’s speed and mode of action work together to slow and suppress development of drug-resistant parasites. Drug resistance has long undermined efforts to treat and block malaria transmission.
“Our goal is to develop an affordable, fast-acting combination therapy that cures malaria with a single dose,” said corresponding author R. Kiplin Guy, Ph.D., chair of the St. Jude Department of Chemical Biology and Therapeutics. “These results indicate that SJ733 and other compounds that act in a similar fashion are highly attractive additions to the global malaria eradication campaign, which would mean so much for the world’s children, who are central to the mission of St. Jude.”
Whole genome sequencing of the Plasmodium falciparum, the deadliest of the malaria parasites, revealed that (+)-SJ733 disrupted activity of the ATP4 protein in the parasites. The protein functions as a pump that the parasites depend on to maintain the proper sodium balance by removing excess sodium.
The sequencing effort was led by co-author Joseph DeRisi, Ph.D., a Howard Hughes Medical Institute investigator and chair of the University of California, San Francisco Department of Biochemistry and Biophysics. Investigators used the laboratory technique to determine the makeup of the DNA molecule in different strains of the malaria parasite.
Researchers showed that inhibiting ATP4 triggered a series of changes in malaria-infected red blood cells that marked them for destruction by the immune system. The infected cells changed shape and shrank in size. They also became more rigid and exhibited other alterations typical of aging red blood cells. The immune system responded using the same mechanism the body relies on to rid itself of aging red blood cells.
Another promising class of antimalarial compounds triggered the same changes in red blood cells infected with the malaria parasite, researchers reported. The drugs, called spiroindolones, also target the ATP4 protein. The drugs include NITD246, which is already in clinical trials for treatment of malaria. Those trials involve investigators at other institutions.
“The data suggest that compounds targeting ATP4 induce physical changes in the infected red blood cells that allow the immune system or erythrocyte quality control mechanisms to recognize and rapidly eliminate infected cells,” DeRisi said. “This rapid clearance response depends on the presence of both the parasite and the investigational drug. That is important because it leaves uninfected red blood cells, also known as erythrocytes, unharmed.”
Laboratory evidence also suggests that the mechanism will slow and suppress development of drug-resistant strains of the parasite, researchers said.
The Latest on: Malaria
via Google News
The Latest on: Malaria
- Say ‘Ok Google, talk to Malaria No More’ on Android devices to get details on diseaseon November 26, 2020 at 4:55 am
Malaria No More India’ with support from Times Bridge, has launched a new tool for Android devices to provide information on the disease and treatment protocols. Malaria No More India (MNM India) is a ...
- Malaria Vaccines Market 2020 Research Study including Growth Factors, Types and Application to 2026on November 25, 2020 at 7:59 am
The malaria vaccines market is expected to reach USD 156.8 million by 2026 according to a new study published by Polaris Market Research.The market for malaria vaccines globally has been divided based ...
- Mosquitoes carry more malaria parasites depending on when they biteon November 24, 2020 at 4:11 pm
When a malaria-infected bird is bitten by mosquitoes over the course of 3 hours, the first insects to feed end up carrying fewer malaria parasites than those that bite later ...
- May & Baker Nigeria eyes growth with new malaria drugon November 24, 2020 at 4:00 pm
Nigeria’s leading pharmaceutical manufacturer, May & Baker Nigeria Plc has introduced a new anti-malarial medicine that promises to revolutionise malaria disease treatment in the country. The new drug ...
- 2020 Eureka Prizes go to a ‘milkshake for malaria’, ABC’s Coronacast and an energy-making sewerage systemon November 24, 2020 at 2:29 am
Seventeen prizes were awarded in this year's ceremony, recognising a diverse group of scientific minds devoted to solving key 21st century issues.
- After Battling Covid, Malaria And Dengue, Man Now Survives Deadly Snakebiteon November 23, 2020 at 4:50 am
After recovering from COVID-19, dengue and malaria, a man in India is currently recuperating from a potentially deadly snake bite. Ian Jones, a charity worker from Britain who has been living in India ...
- After Malaria And Covid, British Man Survives Cobra Bite In Indiaon November 21, 2020 at 7:34 am
A British charity worker who survived coronavirus, dengue and malaria was recovering after a potentially deadly snake bite in western India's Rajasthan state. Ian Jones was bitten by an Indian cobra ...
- Lancaster University to help control the spread of invasive malaria mosquitoon November 20, 2020 at 3:17 pm
Lancaster University is involved in a major research project which aims to control the spread of an invasive malaria mosquito in Sudan and Ethiopia.
- EU Malaria Fund: Sanaria receives substantial investment into its proprietary malaria platformon November 15, 2020 at 7:05 am
On the occasion of the Annual Meeting of the American Society of Tropical Medicine and Hygiene approximately 4,900 global health professionals representing academia, government, and the private sector ...
- Malaria parasites hide out in humans when it's not mosquito seasonon October 27, 2020 at 4:55 am
Malaria parasites survive the mosquito-free dry season by waiting silently in humans for the return of the rainy season that brings back with it mosquitoes. New research, by an international team ...
via Bing News